These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30786001)

  • 1. Functional Genetic Variation in the Anti-Müllerian Hormone Pathway in Women With Polycystic Ovary Syndrome.
    Gorsic LK; Dapas M; Legro RS; Hayes MG; Urbanek M
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2855-2874. PubMed ID: 30786001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of the Anti-Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome.
    Pierre A; Taieb J; Giton F; Grynberg M; Touleimat S; El Hachem H; Fanchin R; Monniaux D; Cohen-Tannoudji J; di Clemente N; Racine C
    J Clin Endocrinol Metab; 2017 Nov; 102(11):3970-3978. PubMed ID: 28938480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome.
    Gorsic LK; Kosova G; Werstein B; Sisk R; Legro RS; Hayes MG; Teixeira JM; Dunaif A; Urbanek M
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2862-2872. PubMed ID: 28505284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of AMH and its receptor SNP in the pathogenesis of PCOS.
    Wang F; Niu WB; Kong HJ; Guo YH; Sun YP
    Mol Cell Endocrinol; 2017 Jan; 439():363-368. PubMed ID: 27664518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients.
    Kevenaar ME; Laven JS; Fong SL; Uitterlinden AG; de Jong FH; Themmen AP; Visser JA
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1310-6. PubMed ID: 18230658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.
    Georgopoulos NA; Karagiannidou E; Koika V; Roupas ND; Armeni A; Marioli D; Papadakis E; Welt CK; Panidis D
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1866-70. PubMed ID: 23969185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
    Zheng MX; Li Y; Hu R; Wang FM; Zhang XM; Guan B
    J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Müllerian Hormone: A Molecular Key to Unlocking Polycystic Ovary Syndrome?
    Abbott DH; Hutcherson BA; Dumesic DA
    Semin Reprod Med; 2024 Mar; 42(1):41-48. PubMed ID: 38908381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome.
    Catteau-Jonard S; Jamin SP; Leclerc A; Gonzalès J; Dewailly D; di Clemente N
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4456-61. PubMed ID: 18697861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome.
    Szafarowska M; Dziech E; Kaleta B; Kniotek M; Rogowski A; Segiet-Święcicka A; Jerzak M
    J Assist Reprod Genet; 2019 Jun; 36(6):1281-1289. PubMed ID: 31089932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS).
    Hoyos LR; Visser JA; McLuskey A; Chazenbalk GD; Grogan TR; Dumesic DA
    Hum Reprod; 2020 Oct; 35(10):2294-2302. PubMed ID: 32918081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study of four key folliculogenesis genes in polycystic ovary syndrome.
    Sproul K; Jones MR; Mathur R; Azziz R; Goodarzi MO
    BJOG; 2010 May; 117(6):756-60. PubMed ID: 20236105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation analysis of anti-Müllerian hormone gene in Chinese women with polycystic ovary syndrome.
    Qin L; Zhao S; Yang P; Cao Y; Zhang J; Chen ZJ; Dunaif A; Zhao H
    Endocrine; 2021 Apr; 72(1):287-293. PubMed ID: 33169290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of Polycystic Ovary Syndrome (PCOS).
    Zhong X; Jin F; Huang C; Du M; Gao M; Wei X
    Technol Health Care; 2021; 29(S1):11-25. PubMed ID: 33682741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial expression of anti-Müllerian hormone and its type II receptor in women with polycystic ovary syndrome.
    Paulson M; Sahlin L; Hirschberg AL
    Reprod Biomed Online; 2020 Jul; 41(1):128-137. PubMed ID: 32444258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dominant negative mutation at the ATP binding domain of AMHR2 is associated with a defective anti-Müllerian hormone signaling pathway.
    Li L; Zhou X; Wang X; Wang J; Zhang W; Wang B; Cao Y; Kee K
    Mol Hum Reprod; 2016 Sep; 22(9):669-78. PubMed ID: 27430550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms with idiopathic primary ovarian insufficiency.
    Yoon SH; Choi YM; Hong MA; Kim JJ; Lee GH; Hwang KR; Moon SY
    Hum Reprod; 2013 Dec; 28(12):3301-5. PubMed ID: 24146295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.